Success Metrics

Clinical Success Rate
81.8%

Based on 36 completed trials

Completion Rate
82%(36/44)
Active Trials
0(0%)
Results Posted
31%(11 trials)
Terminated
8(14%)

Phase Distribution

Ph not_applicable
7
12%
Ph phase_1
3
5%
Ph phase_3
11
19%
Ph phase_4
30
52%
Ph phase_2
6
10%

Phase Distribution

3

Early Stage

6

Mid Stage

41

Late Stage

Phase Distribution57 total trials
Phase 1Safety & dosage
3(5.3%)
Phase 2Efficacy & side effects
6(10.5%)
Phase 3Large-scale testing
11(19.3%)
Phase 4Post-market surveillance
30(52.6%)
N/ANon-phased studies
7(12.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

36 of 44 finished

Non-Completion Rate

18.2%

8 ended early

Currently Active

0

trials recruiting

Total Trials

58

all time

Status Distribution
Active(1)
Completed(36)
Terminated(8)
Other(13)

Detailed Status

Completed36
unknown13
Terminated8
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
58
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (5.3%)
Phase 26 (10.5%)
Phase 311 (19.3%)
Phase 430 (52.6%)
N/A7 (12.3%)

Trials by Status

unknown1322%
not_yet_recruiting12%
terminated814%
completed3662%

Recent Activity

Clinical Trials (58)

Showing 20 of 58 trialsScroll for more
NCT07122102Not Applicable

A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes

Not Yet Recruiting
NCT02953093Phase 2

Study of Acarbose in Longevity

Terminated
NCT01514838Phase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Terminated
NCT03380546Phase 3

Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.

Terminated
NCT02589353Phase 4

Human Oral Detection of Glucose Olygomers

Completed
NCT05629806Phase 3

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

Unknown
NCT02446834Not Applicable

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Completed
NCT04180813

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Terminated
NCT03794336Phase 4

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Completed
NCT03359837Phase 4

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

Completed
NCT02836704Phase 4

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Completed
NCT01019356Not Applicable

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Completed
NCT03344341Phase 4

A Phase IV Study in Drug-Naive Patients With T2DM in China

Terminated
NCT01914133Phase 2

Acarbose and Older Adults With Postprandial Hypotension

Completed
NCT02685852Phase 1

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Completed
NCT01490918Phase 4

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Completed
NCT03349684Phase 3

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Completed
NCT01181674Phase 4

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Completed
NCT03241303Not Applicable

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Completed
NCT02072096Phase 4

A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
58